A novel cryptic exon identified in the 3′ region of intron 2 of the human dystrophin gene

Journal of Human Genetics

Volumn 50, Issue 8, 2005, Pages 425-433

  Tran, Van Khanh ^a   Zhang, Zhujun ^a   Yagi, Mariko ^a   Nishiyama, Atsushi ^a   Habara, Yasuaki ^a   Takeshima, Yasuhiro ^a   Matsuo, Masafumi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CASE REPORT; DUCHENNE MUSCULAR DYSTROPHY; EXON; GENE AMPLIFICATION; GENE DUPLICATION; GENE IDENTIFICATION; GENE INSERTION; GENE LOCATION; GENE MUTATION; GENETIC TRANSCRIPTION; HEART MUSCLE; HUMAN; INTRON; MALE; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SKELETAL MUSCLE;

3' UNTRANSLATED REGIONS; ALTERNATIVE SPLICING; BASE SEQUENCE; CHILD, PRESCHOOL; CONSENSUS SEQUENCE; CONSERVED SEQUENCE; DNA; DYSTROPHIN; EXONS; HUMANS; INTRONS; JAPAN; LYMPHOCYTES; MALE; MOLECULAR SEQUENCE DATA; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICE SITES; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC;

EID: 25444529489     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-005-0272-6     Document Type: Article

References (46)

1. Adachi K, Takeshima Y, Wada H, Yagi M, Nakamura H, Matsuo M (2003) Heterogous dystrophin mRNAs produced by a novel splice acceptor site mutation in intermediate dystrophinopathy. Pediatr Res 53:125-131
2. Ahn AH, Kunkel LM (1993) The structural and functional diversity of dystrophin. Nat Genet 3:283-291
3. Ars E, Serra E, Garcia J, Kruyer H, Gaona A, Lazaro C, Estivill X (2000) Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 9:237-247
4. Bardoni A, Felisari G, Sironi M, Comi G, Lai M, Robotti M, Bresolin N (2000) Loss of Dp140 regulatory sequences is associated with cognitive impairment in dystrophinopathies. Neuromuscul Disord 10:194-199
5. Beggs AH, Koenig M, Boyce FM, Kunkel LM (1990) Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 86:45-48
6. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR (2003) ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31:3568-3571
7. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT (1988) Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 16:11141-11156
8. Chelly J, Gilgenkrantz H, Hugnot J, Hamard G, Lambert M, Recan D, Akli S, Cometto M, Kahn A, Kaplan J (1991) Illegitimate transcription. Application to the analysis of truncated transcripts of the dystrophin gene in nonmuscle cultured cells from Duchenne and Becker patients. J Clin Invest 88:1161-1166
9. Chillon M, Dork T, Casals T, Gimenez J, Fonknechten N, Will K, Ramos D, Nunes V, Estivill X (1995) A novel donor splice site in intron 11 of the CFTR gene, created by mutation 1811 + 1.6kbA → G, produces a new exon: high frequency in Spanish cystic fibrosis chromosomes and association with severe phenotype. Am J Hum Genet 56:623-629
10. Cooper TA, Mattox W (1997) The regulation of splice-site selection, and its role in human disease. Am J Hum Genet 61:259-266
11. D'Souza VN, Nguyen TM, Morris GE, Karges W, Pillers DA, Ray PN (1995) A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet 4:837-842
12. Dwi Pramono ZA, Takeshima Y, Surono A, Ishida T, Matsuo M (2000) A novel cryptic exon in intron 2 of the human dystrophin gene evolved from an intron by acquiring consensus sequences for splicing at different stages of anthropoid evolution. Biochem Biophys Res Commun 267:321-328
13. Eng L, Coutinho G, Nahas S, Yeo G, Tanouye R, Babaei M, Dork T, Burge C, Gatti RA (2004) Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths. Hum Mutat 23:67-76
14. Felisari G, Martinelli Boneschi F, Bardoni A, Sironi M, Comi GP, Robotti M, Turconi AC, Lai M, Corrao G, Bresolin N (2000) Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy. Neurology 55:559-564
15. Ferlini A, Muntoni F (1998) The 5′ region of intron 11 of the dystrophin gene contains target sequences for mobile elements and three overlapping ORFs. Biochem Biophys Res Commun 242:401-406
16. Ferlini A, Sewry C, Melis MA, Mateddu A, Muntoni F (1999) X-linked dilated cardiomyopathy and the dystrophin gene. Neuromuscul Disord 9:339-346
17. Galante PA, Sakabe NJ, Kirschbaum-Slager N, de Souza SJ (2004) Detection and evaluation of intron retention events in the human transcriptome. Rna 10:757-765
18. Giliberto F, Ferreiro V, Dalamon V, Szijan I (2004) Dystrophin deletions and cognitive impairment in Duchenne/Becker muscular dystrophy. Neurol Res 26:83-87
19. Graveley BR (2005) Small molecule control of pre-mRNA splicing. Rna 11:355-358
20. -1 to T) in a 5′ splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy. Am J Hum Genet 54:53-61
21. Highsmith WE, Burch LH, Zhou Z, Olsen JC, Boat TE, Spock A, Gorvoy JD, Quittel L, Friedman KJ, Silverman LM et al (1994) A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med 331:974-980
22. Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41-54
23. Malhotra SB, Hart KA, Klamut HJ, Thomas NST, Bodrug E, Burghes AHM, Borrow M, Harper PS, Thompson W, Ray PN, Worton RG (1988) Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science 242:755-759
24. Matsuo M, Masumura T, Nishio H, Nakajima T, Kitoh Y, Takumi T, Koga J, Nakamura H (1991) Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy Kobe. J Clin Invest 87:2127-2131
25. Muntoni F, Gobbi P, Sewry C, Sherratt T, Taylor J, Sandhu SK, Abbs S, Roberts R, Hodgson SV, Bobrow M, Dubowits V (1994) Deletions in the 5′ region of dystrophin and resulting phenotypes. J Med Genet 31:843-847
26. Nishio H, Takeshima Y, Narita N, Yanagawa H, Suzuki Y, Ishikawa Y, Minami R, Nakamura H, Matsuo M (1994) Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter. J Clin Invest 94:1037-1042
27. Pagani F, Buratti E, Stuani C, Bendix R, Dork T, Baralle FE (2002) A new type of mutation causes a splicing defect in ATM. Nature Genet 30:426-429
28. Reiss J, Rininsland F (1994) An explanation for the constitutive exon 9 cassette splicing of the DMD gene. Hum Mol Genet 3:295-298
29. Roberts RG, Bentley DR, Bobrow M (1993) Infidelity in the structure of ectopic transcripts: a novel exon in lymphocyte dystrophin transcripts. Hum Mutat 2:293-299
30. Roca X, Sachidanandam R, Krainer AR (2003) Intrinsic differences between authentic and cryptic 5′ splice sites. Nucleic Acids Res 31:6321-6333
31. Schaal TD, Maniatis T (1999) Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences. Mol Cell Biol 19:1705-1719
32. Senapathy P, Shapiro MB, Harris NL (1990) Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. Methods Enzymol 183:252-278
33. Shapiro MB, Senapathy P (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15:7155-7174
34. Sironi M, Menozzi G, Riva L, Cagliani R, Comi GP, Bresolin N, Giorda R, Pozzoli U (2004) Silencer elements as possible inhibitors of pseudoexon splicing. Nucleic Acids Res 32:1783-1791
35. Suminaga R, Takeshima Y, Adachi K, Yagi M, Nakamura H, Matsuo M (2002) A novel cryptic exon in intron 3 of the dystrophin gene was incorporated into dystrophin mRNA with a single nucleotide deletion in exon 5. J Hum Genet 47:196-201
36. Sun H, Chasin LA (2000) Multiple splicing defects in an intronic false exon. Mol Cell Biol 20:6414-6425
37. Surono A, Takeshima Y, Wibawa T, Pramono ZA, Matsuo M (1997) Six novel transcripts that remove a huge intron ranging from 250 to 800 kb are produced by alternative splicing of the 5′ region of the dystrophin gene in human skeletal muscle. Biochem Biophys Res Commun 239:895-899
38. Surono A, Takeshima Y, Wibawa T, Ikezawa M, Nonaka I, Matsuo M (1999) Circular dystrophin RNAs consisting of exons that were skipped by alternative splicing. Hum Mol Genet 8:493-500
39. Torelli S, Muntoni F (1996) Alternative splicing of dystrophin exon 4 in normal human muscle. Hum Genet 97:521-523
40. Tuffery-Giraud S, Saquet C, Chambert S, Claustres M (2003) Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy. Hum Mutat 21:608-614
41. Vervoort R, Gitzelmann R, Lissens W, Liebaers I (1998) A mutation (IVS8 + 0.6kbdelTC) creating a new donor splice site activates a cryptic exon in an Alu-element in intron 8 of the human beta-glucuronidase gene. Hum Genet 103:686-693
42. Wang M, Dotzlaw H, Fuqua SAW, Murphy LC (1997) A point mutation in the human estrogen receptor gene is associated with the expression of an abnormal estrogen receptor mRNA containing a 69 novel nucleotide insertion. Breast Cancer Res Treat 44:145-151
43. Winnard AV, Jia-Hsu Y, Gibbs RA, Mendell JR, Burghes AH (1992) Identification of a 2 base pair nonsense mutation causing a cryptic splice site in a DMD patient. Hum Mol Genet 1:645-646
44. Winnard AV, Mendell JR, Prior TW, Florence J, Burghes HM (1995) Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Am J Hum Genet 56:158-166
45. Wuarin J, Schibler U (1994) Physical isolation of nascent RNA chains transcribed by RNA polymerase II: evidence for co-transcriptional splicing. Mol Cell Biol 14:7219-7225
46. Yagi M, Takeshima Y, Wada H, Nakamura H, Matsuo M (2003) Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy. Hum Genet 112:164-170